This site is intended for healthcare professionals
News

Actemra does not meet endpoints in phase III COVACTA study for severe COVID-19 associated pneumonia.- Genentech/Roche

Read time: 1 mins
Last updated:30th Jul 2020
Published:30th Jul 2020
Condition: Coronavirus/COVID-19 Infection
Type: drug
Register free for full access to medthority.com